Ionis Pharmaceuticals Statistics, Revenue Totals, Facts & News (2022)

What is Ionis Pharmaceuticals?

For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing the standard of care with its novel antisense technology. Ionis currently has three approved medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies. (source)

Ionis Pharmaceuticals Employee Count

Number of Ionis Pharmaceuticals employees:

817 employees

Last updated 2/21/20

---

Ionis Pharmaceuticals Revenue Totals

Ionis Pharmaceuticals annual revenue:

• 2019: $1.122 billion
• 2018: $599.7 billion
• 2017: $514.2 billion
• 2016: $372.8 billion
• 2015: $283.7 billion

---

Ionis Pharmaceuticals annual net income:

• 2019: $294 million
• 2018: $273 million
• 2017: $300,000
• 2016: $60 million net loss
• 2015: $88 million net loss

---

Recent Ionis Pharmaceuticals News

• Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA, 01/05/2022

---

Please note that some of these numbers are easier to find than others. A few of these Ionis Pharmaceuticals stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.